AI assistant
Sending…
Disc Medicine, Inc. — Director's Dealing 2021
Apr 14, 2021
31589_dirs_2021-04-14_e50de9e5-74f6-44e3-adb2-01888df10aea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Gemini Therapeutics, Inc. /DE (GMTX)
CIK: 0001816736
Period of Report: 2021-04-12
Reporting Person: Barone Samuel B. (Chief Medical Officer)
More from Disc Medicine, Inc.
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 26
Earnings Release
2026
Feb 26
Director's Dealing
2026
Feb 19